王晓童, 董杨勇, 王冉, 张毓萱, 陈静宜, 王同尧, 邱小燕, 肖雄. 应用外泌体microRNA诊治心肌梗死的研究进展J. 药学学报, 2025, 60(5): 1285-1296. DOI: 10.16438/j.0513-4870.2024-1093
引用本文: 王晓童, 董杨勇, 王冉, 张毓萱, 陈静宜, 王同尧, 邱小燕, 肖雄. 应用外泌体microRNA诊治心肌梗死的研究进展J. 药学学报, 2025, 60(5): 1285-1296. DOI: 10.16438/j.0513-4870.2024-1093
WANG Xiao-tong, DONG Yang-yong, WANG Ran, ZHANG Yu-xuan, CHEN Jing-yi, WANG Tong-yao, QIU Xiao-yan, XIAO Xiong. Research progresses in diagnosis and treatment of myocardial infarction with exosomal microRNAJ. Acta Pharmaceutica Sinica, 2025, 60(5): 1285-1296. DOI: 10.16438/j.0513-4870.2024-1093
Citation: WANG Xiao-tong, DONG Yang-yong, WANG Ran, ZHANG Yu-xuan, CHEN Jing-yi, WANG Tong-yao, QIU Xiao-yan, XIAO Xiong. Research progresses in diagnosis and treatment of myocardial infarction with exosomal microRNAJ. Acta Pharmaceutica Sinica, 2025, 60(5): 1285-1296. DOI: 10.16438/j.0513-4870.2024-1093

应用外泌体microRNA诊治心肌梗死的研究进展

Research progresses in diagnosis and treatment of myocardial infarction with exosomal microRNA

  • 摘要: 心肌梗死会严重危害人类和动物健康, 亟待提升其诊断速度和治疗效果。外泌体作为天然的细胞信息载体, 其包含的一些微小RNA (microRNA, miRNA) 能够反映或作用于心肌梗死所致病理变化, 进行有效诊治。本文就不同来源的外泌体miRNA作为心肌梗死诊断物(如miR-4516、miR-203和miR-1915-3p) 的可行性, 以及通过细胞凋亡(如miR-21a-5p、miR-30e和miR-210)、细胞自噬(如miR-125b-5p、miR-301和miR-143-3p)、细胞焦亡(如miR-182-5p、miR-133a和miR-100-5p) 和铁死亡(如miR-26b-5p和miR-23a-3p) 减缓细胞死亡, 促进新生血管的形成(如miR-29b-3p、miR-210-3p和miR-494-3p) 和抑制炎症反应(如miR-25-3p、miR-182-5p和miR-671) 等作用对心肌梗死进行干预治疗的研究进展进行了综述, 旨在为心肌梗死的诊断和治疗提供新策略。

     

    Abstract: Human and animal health will be seriously harmed by myocardial infarction, the diagnostic speed and the therapeutic effect of this disease need to be improved urgently. As the natural carrier for delivering cell information, some microRNAs (miRNAs) found in exosomes can reflect and act on the pathological changes caused by myocardial infarction for effective diagnosis and treatment. The feasibility of exosomal miRNAs (e.g. miR-4516, miR-203, and miR-1915-3p) from different sources as diagnostic agents for myocardial infarction, as well as the research progresses in relief of cell death via apoptosis (e.g. miR-21a-5p, miR-30e, and miR-210), autophagy (e.g. miR-125b-5p, miR-301, and miR-143-3p), pyroptosis (e.g. miR-182-5p, miR-133a, and miR-100-5p), and ferroptosis (e.g. miR-26b-5p and miR-23a-3p), promotion of forming new blood vessels (e.g. miR-29b-3p, miR-210-3p, and miR-494-3p), and inhibition of inflammatory response (e.g. miR-25-3p, miR-182-5p, and miR-671) for intervention therapy of myocardial infarction were reviewed here to provide new strategies for the diagnosis and treatment of myocardial infarction.

     

/

返回文章
返回